Bioadaptives Inc (BDPT) 0.1500 $BDPT
CORRECTION - Gawk CEO Outlines Company's Future on Money For Lunch Online Radio Interview
Marketwired - Wed Aug 19, 11:37AM CDT
In the news release, "Gawk CEO Outlines Company's Future on Money For Lunch Online Radio Interview" issued earlier today by Gawk, Inc. (OTC PINK: GAWK), we are advised by the company that the radio interview link in the fifth paragraph has been updated. Complete corrected text follows.
Gawk CEO Outlines Company's Future on Money For Lunch Online Radio Interview
Marketwired - Wed Aug 19, 7:30AM CDT
GAWK Inc. (OTC PINK: GAWK) CEO Scott Kettle will be interviewed tomorrow on Money For Lunch Talk Show, at 12:45 pm CDT, by host Bert Martinez, and will detail the Company's plans through the balance of the year. Kettle will discuss what GAWK's revenue will look like for the 2nd quarter and beyond, its plans to acquire other data centers, recent customer wins, and plans to enlarge GAWK's footprint beyond the U.S.
Gawk Customer Win, Signs Agreement With BioAdaptives, Inc.
Marketwired - Tue Aug 18, 7:30AM CDT
GAWK Inc. (OTC PINK: GAWK), through its wholly owned subsidiary, WebRunners, Inc., announced today a signature client win with the signing of an agreement with BioAdaptives, Inc. (OTCBB: BDPT), in conjunction with the Company rolling out its first five products nationwide.
BioAdaptives, Inc. Announces Nationwide Product Roll-Out
Marketwired - Tue Jun 30, 11:39AM CDT
After years of exhaustive research and development, the BioAdaptives team (OTCBB: BDPT) is excited to reveal the first five products in our nationwide roll-out, taking place in the third quarter of 2015.
BioAdaptives (OTCBB:BDPT) Announces New President
PR Newswire - Fri Feb 06, 7:43AM CST
BioAdaptives, Inc., a fully-reporting public company trading under the ticker symbol: (OTCBB: BDPT), announced that Mr. Christopher G. Hall has been selected to lead the company going forward as its new President, with additional titles of Chief Executive Officer, Chief Financial Officer, and Secretary.
BioAdaptives Announces New Trial Showing PrimiCell® Improved Muscle Repair by over 56%
PR Newswire - Sun Dec 07, 7:57PM CST
BioAdaptives, Inc. (BDPT) announced results of the recently completed in vivo trial showing the efficacy of its PrimiCell® product on muscle repair.
CORRECTION - Gawk CEO Outlines Company's Future on Money For Lunch Online Radio Interview
Marketwired - Wed Aug 19, 11:37AM CDT
In the news release, "Gawk CEO Outlines Company's Future on Money For Lunch Online Radio Interview" issued earlier today by Gawk, Inc. (OTC PINK: GAWK), we are advised by the company that the radio interview link in the fifth paragraph has been updated. Complete corrected text follows.
Gawk CEO Outlines Company's Future on Money For Lunch Online Radio Interview
Marketwired - Wed Aug 19, 7:30AM CDT
GAWK Inc. (OTC PINK: GAWK) CEO Scott Kettle will be interviewed tomorrow on Money For Lunch Talk Show, at 12:45 pm CDT, by host Bert Martinez, and will detail the Company's plans through the balance of the year. Kettle will discuss what GAWK's revenue will look like for the 2nd quarter and beyond, its plans to acquire other data centers, recent customer wins, and plans to enlarge GAWK's footprint beyond the U.S.
Gawk Customer Win, Signs Agreement With BioAdaptives, Inc.
Marketwired - Tue Aug 18, 7:30AM CDT
GAWK Inc. (OTC PINK: GAWK), through its wholly owned subsidiary, WebRunners, Inc., announced today a signature client win with the signing of an agreement with BioAdaptives, Inc. (OTCBB: BDPT), in conjunction with the Company rolling out its first five products nationwide.
BioAdaptives, Inc. Announces Nationwide Product Roll-Out
Marketwired - Tue Jun 30, 11:39AM CDT
After years of exhaustive research and development, the BioAdaptives team (OTCBB: BDPT) is excited to reveal the first five products in our nationwide roll-out, taking place in the third quarter of 2015.
BioAdaptives (OTCBB:BDPT) Announces New President
PR Newswire - Fri Feb 06, 7:43AM CST
BioAdaptives, Inc., a fully-reporting public company trading under the ticker symbol: (OTCBB: BDPT), announced that Mr. Christopher G. Hall has been selected to lead the company going forward as its new President, with additional titles of Chief Executive Officer, Chief Financial Officer, and Secretary.
BioAdaptives Announces New Trial Showing PrimiCell® Improved Muscle Repair by over 56%
PR Newswire - Sun Dec 07, 7:57PM CST
BioAdaptives, Inc. (BDPT) announced results of the recently completed in vivo trial showing the efficacy of its PrimiCell® product on muscle repair.
